Jennifer L. Taubert - Feb 14, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, Pharmaceuticals
Signature
Raavi K. Deol, as attorney-in-fact for Jennifer L. Taubert
Stock symbol
JNJ
Transactions as of
Feb 14, 2022
Transactions value $
$11,813,690
Form type
4
Date filed
2/17/2022, 05:01 AM
Next filing
Oct 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +18.1K +15.41% $0.00 135K Feb 15, 2022 Direct F1
transaction JNJ Common Stock Tax liability -$1.47M -8.84K -6.53% $165.89 126K Feb 15, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Award $13.3M +80.1K $165.89 80.1K Feb 14, 2022 Common Stock 80.1K Direct F3
transaction JNJ Restricted Share Units Award $0 +4.05K $0.00 4.05K Feb 14, 2022 Common Stock 4.05K Direct F4
transaction JNJ Performance Share Units Options Exercise $0 -18.1K -91.3% $0.00 1.72K Feb 15, 2022 Common Stock 18.1K Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Performance Share Units.
F3 Awarded under Issuer's Long-Term Incentive Plan.
F4 Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.
F5 Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.